EUCTR2012-004946-13-BE进行中（未招募）不适用
Impact of timolol/dorzolamide therapy on autoregulation in glaucoma patients
niversity Hospitals Leuven0 个研究点开始时间: 2013年8月29日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients over 18 years old
- •Willing to give a written consent
- •Patient with primary-open angle glaucoma
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •history of ocular trauma
- •intraocular surgery (except for cataract surgery)
- •eye disease associated with hemodynamic disturbances (except glaucoma)
- •systemic diseases with ocular involvement like diabetes
- •contra-indications to the use of topical beta-blockers or carbonic anhydrase inhibitors
研究者
相似试验
已完成
不适用
Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analoguesprimary open angle glaucoma and ocular hypertensionJPRN-UMIN000006828Hospital, University of the Ryukyus40
已完成
不适用
Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues and CAIGlaucomaJPRN-UMIN000006830Hospital, University of the Ryukyus20
已完成
不适用
Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues and beta-blockerGlaucomaJPRN-UMIN000006829Hospital, University of the Ryukyus20
已完成
不适用
Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues, beta-blocker and CAIJPRN-UMIN000006831Hospital, University of the Ryukyus20
已完成
不适用
Evaluation of dorzolamide/timolol fixed combination therapy for the patients who need more IOP reduction under PG analoguesprimary open angle glaucoma, ocular hypertensionJPRN-UMIN000004596Department of Ophthalmology, Kyoto Prefectural University of Medicine40